FindTrial
Sign In

Efficacy of virtual reality exposure therapy for the fear of flying.

Efficacy of virtual reality exposure therapy for the fear of flying: a randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7fqyyd
Enrollment
Unknown
Registered
2019-03-04
Start date
2018-09-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panic disorder, Agoraphobia.

Interventions

After an initial interview and confirm the participation on the study, the first session will be scheduled with the participant. Such session will be comprised of the signature of the participation co
Beck's Depression Inventory (BDI)
FAS (Flight Anxiety Situations Questionnaire)
FAM (Flight Anxiety Modality Questionnaire) and CGI (Clinical Global Impression). The patient will be questioned about their usage of medication (which must be stable for the duration of the study). T
Behavioural
Other
F40.2

Sponsors

Universidade Federal do Rio de Janeiro
Lead Sponsor
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Collaborator
Universidade Federal do Rio de Janeiro
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: DSM criteria for specific phobia of airplanes; subclinical panic disorders; subclinical agoraphobia (provided that panic symptoms do not interfere with VR exposure); generalized anxiety disorder (GAD), since flying is the main stimulus of fear; signing a form consent.

Exclusion criteria

Exclusion criteria: Participants who are not literate; psychopathological disorder that require immediate treatment; suicide risk; mentally retarded; dependence of psychoactive substances; cardiovascular or respiratory disease presenting some risk; pregnant; psychotic disorder; antisocial personality disorder; schizophrenia; mania; participants in concomitant psychotherapeutic treatments; epilepsy.

Design outcomes

Primary

MeasureTime frame
Will cause levels of discomfort when participants are imemersed in VR, verified by Flight Anxiety Situations Questionnaire (FAS) and Flight Anxiety Modality Questionnaire (FAM). (Using cutting levels suggests by literature).—

Secondary

MeasureTime frame
Will pertinent to know the rates of involvement and improvement under VR; shall be verified by Igroup Presence Questionnaire (IPQ), Sickness Questionnaire, Clinical Global Impression (CGI), Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI). Will use cutting levels suggests by literature).—

Countries

Brazil

Contacts

Public ContactPaula Ventura

Universidade Federal do Rio de Janeiro

tepteviolenciaurbana@gmail.com+55-021-39385535

Outcome results

None listed

Source: REBEC (via WHO ICTRP)